Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma

Small cell lung carcinoma (SCLC) is a highly aggressive form of malignancy with rapid recurrence and poor prognosis. The dual peptide-modified nanoparticles (NPs) for improving chemotherapy against drug-resistant small cell lung carcinoma cells has been developed. In this study, the SCLC targeting l...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Hsin-Lin Huang, Wen Jen Lin
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Subjects:	small cell lung carcinoma drug-resistance antagonist g peptide etoposide sipik3ca
Online Access:	https://www.mdpi.com/1999-4923/12/3/254